Singapore, April 16 -- Shionogi & Co. has made an equity investment in Restore Vision Inc, a Tokyo-based startup company developing innovative technologies in the field of ophthalmology. This investment represents Shionogi's first investment under its Corporate Venture Capital (CVC) activities.

In April 2025, Shionogi established its Corporate Venture Capital (CVC) to explore next-generation growth opportunities in new markets and technology areas. The CVC targets a broad range of investment areas beyond pharmaceuticals, including technology, infrastructure, and resources. Through these activities, Shionogi seeks to create new value that contributes to addressing social challenges and advancing healthcare.

Through its CVC activities, Sh...